|
|
||||||||
,
,§
Departments of
*
Surgery,
Pathology, and
Molecular Virology, Immunology, and Medical Genetics, and
§
Comprehensive Cancer Center, Ohio State University College of Medicine, Columbus, OH 43210
We have used delayed-type hypersensitivity (DTH) responses to probe
the mechanisms of drug-induced cardiac allograft acceptance in mice.
DBA/2
C57BL/6 cardiac allograft recipients treated transiently with
gallium nitrate accept their grafts for >90 days and fail to display
DBA/2-reactive DTH responses. These DTH responses are restored when
anti-TGF-ß Abs are included at the challenge site, and cell
depletion studies showed that this DTH inhibition is mediated by
CD4+ cells. Real-time PCR analysis revealed that allograft
acceptor mice produce no more than background levels of TGF-ß mRNA at
DTH challenge sites. This suggests that DTH regulation in allograft
acceptor mice may involve TGF-ß activation, rather than TGF-ß
production. The protease, plasmin, can activate TGF-ß, and activated
T cells can express a receptor for the plasmin-producing enzyme
urokinase-type plasminogen activator (uPA), and can also produce both
uPA and tissue-type plasminogen activator (tPA). We observed that Abs
to tPA or uPA can replace anti-TGF-ß mAb for the restoration of
donor-reactive DTH responses in allograft acceptor mice. Histologic
analysis revealed that accepted cardiac allografts express uPA, tPA,
and active TGF-ß, whereas accepted cardiac isografts express only
tPA, but not uPA or activated TGF-ß. These data demonstrate that
local tPA and uPA contribute to DTH regulation in allograft acceptor
mice and suggest that these elements of the fibrinolytic pathway are
used to control donor-reactive cell-mediated immunity in allograft
acceptor mice.
This article has been cited by other articles:
![]() |
M. Stojakovic, L. I. Salazar-Fontana, Z. Tatari-Calderone, V. P. Badovinac, F. R. Santori, D. Kovalovsky, D. Sant'Angelo, J. T. Harty, and S. Vukmanovic Adaptable TCR Avidity Thresholds for Negative Selection J. Immunol., November 15, 2008; 181(10): 6770 - 6778. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. T. H. Roelofs, K. M. A. Rouschop, G. J. D. Teske, G. T. M. Wagenaar, N. Claessen, J. J. Weening, T. van der Poll, and S. Florquin Endogenous tissue-type plasminogen activator is protective during ascending urinary tract infection Nephrol. Dial. Transplant., October 8, 2008; (2008) gfn562v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bogunovic, M. Stojakovic, L. Chen, and M. Maric An Unexpected Functional Link between Lysosomal Thiol Reductase and Mitochondrial Manganese Superoxide Dismutase J. Biol. Chem., April 4, 2008; 283(14): 8855 - 8862. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ilkovitch, M. E. Handel-Fernandez, L. M. Herbert, and D. M. Lopez Antitumor Effects of Mucin 1/sec Involves the Modulation of Urokinase-Type Plasminogen Activator and Signal Transducer and Activator of Transcription 1 Expression in Tumor Cells Cancer Res., April 1, 2008; 68(7): 2427 - 2435. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Cook, A. A. Bickerstaff, J.-J. Wang, T. Nadasdy, P. Della Pelle, R. B. Colvin, and C. G. Orosz Spontaneous Renal Allograft Acceptance Associated with "Regulatory" Dendritic Cells and IDO J. Immunol., March 1, 2008; 180(5): 3103 - 3112. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Sonoda, T. Nakamura, H. A. Young, D. Hart, P. Carmeliet, and J. Stein-Streilein NKT Cell-Derived Urokinase-Type Plasminogen Activator Promotes Peripheral Tolerance Associated with Eye J. Immunol., August 15, 2007; 179(4): 2215 - 2222. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamaguchi, K. Yamada, T. Suzuki, Y.-P. Wu, K. Kita, S. Takahashi, M. Ichinose, and N. Suzuki Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP) Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E970 - E976. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Bishop, S. C. Wood, E. J. Eichwald, and C. G. Orosz Immunobiology of Allograft Rejection in the Absence of IFN-{{gamma}}: CD8+ Effector Cells Develop Independently of CD4+ Cells and CD40-CD40 Ligand Interactions J. Immunol., March 1, 2001; 166(5): 3248 - 3255. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |